High potency recombinant antibodies and method for producing them

Details for Australian Patent Application No. 2012211451 (hide)

Owner MedImmune, LLC Applied Molecular Evolution, Inc.

Inventors Wu, Herren; Young, James F.; Watkins, Jeffry D.; Johnson, Leslie S.; Koenig, Scott; Huse, William D.

Agent Spruson & Ferguson

Pub. Number AU-A-2012211451

Parent 2010219289

Filing date 9 August 2012

Wipo publication date 30 August 2012

International Classifications

G01N 33/557 Investigating or analysing materials by specific methods not covered by groups - using kinetic measurement, i.e. time rate of progress of an antigen-antibody interaction

A61K 38/00 Medicinal preparations containing peptides

A61K 39/395 Medicinal preparations containing antigens or antibodies - Antibodies

A61P 31/12 Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

C07K 16/00 Immunoglobulins, e.g. monoclonal or polyclonal antibodies

C07K 16/10 Immunoglobulins, e.g. monoclonal or polyclonal antibodies

C07K 16/30 Immunoglobulins, e.g. monoclonal or polyclonal antibodies

C12N 15/09 Mutation or genetic engineering - Recombinant DNA-technology

C12P 21/02 Preparation of peptides or proteins - having a known sequence of two or more amino acids, e.g. glutathione

Event Publications

23 August 2012 Complete Application Filed

30 August 2012 Application Open to Public Inspection

  Published as AU-A-2012211451

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2012211452-Joint structure of column and steel pipe pile

2012211450-Gaming machine and game control method thereof